Post-marketing surveillance should include effects during pregnancy.
Yeargin
Patricia
P
D016907:Adverse Drug Reaction Reporting Systems; D044966:Anti-Retroviral Agents; D000075202:Contraindications; D005260:Female; D006801:Humans; D011247:Pregnancy; D011248:Pregnancy Complications / Q000139:chemically induced*
D044966:Anti-Retroviral Agents